Chill Brands Share Discussion Threads

[vlad the impaler] 28/4/2024 17:07

Noticed something about opti and bulgaria in a report

[vlad the impaler] 28/4/2024 17:06

Frankly i dont read any of theirs either. But we all still post

[purchaseatthetop] 28/4/2024 17:04

Frankly nobody reads any of your nonsense. Don’t worry about it?

[vlad the impaler] 28/4/2024 17:01

i am scatter gunning here aint I.. we need a sound mind from somewhere, to take it all apart, piece by piece.

[vlad the impaler] 28/4/2024 16:53

ProBiotix has raised £1.025 million of capital through the issue of convertible loan notes ("CLN")
The CLNs can be converted at a fifty per cent. discount to the issue price of ProBiotix shares in the event of an IPO. The CLNs carry an interest rate of 3% per annum above the Bank of England Base Rate.
...

ok so. what percentage of the float does that represent?

It ought to be no more than circa 10% the IPO float given CLN value

But what are the facts re percentage of float owned by CLN conversions

[vlad the impaler] 28/4/2024 16:51

RNS & Investor News
Issue of Convertible Loan Notes by ProBiotix and Related Party Transaction
14 December 2018

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that further to the announcement on 24 September 2018 regarding the formation of the Company's wholly owned subsidiary ProBiotix Health Limited ("ProBiotix"), ProBiotix has raised £1.025 million of capital through the issue of convertible loan notes ("CLN").

The proceeds from the issue of CLNs will be used to provide funding for a potential initial public offering of ProBiotix. This is in line with OptiBiotix's strategy announced on 5 July 2016 to form separate divisions, which could in due course become separate legal entities with the potential for a separate public listing. OptiBiotix's strategy is based on its belief that the diversity of IP and commercial relationships across its four divisions reduces shareholder risk whilst offering multiple opportunities for value enhancement.

OptiBiotix plc has subscribed for £250,000 of CLNs. Steve O'Hara, a director of the Company, has subscribed for £25,000 and certain close family members of Mr. O'Hara have subscribed for £265,000. In addition, Per Rehné, a director of the Company, has subscribed for £25,000. The remaining subscribers include two institutional investors and two industry partners.

The CLNs can be converted at a fifty per cent. discount to the issue price of ProBiotix shares in the event of an IPO. The CLNs carry an interest rate of 3% per annum above the Bank of England Base Rate.

As of 14 December 2018, Steve O'Hara has an interest in 10,103,029 ordinary shares in the Company, representing 11.9 per cent. of the Company's issued share capital and has an interest in a further 6,099,135 ordinary shares under option.

Related Party Transaction

For the purposes of the issue of CLNs, the participation of Steve O'Hara and his close family members and Per Rehné is being treated as a related party transaction ("Transaction") for the purposes of Rule 13 of the AIM Rules for Companies. The directors of the Company independent of the Transaction, having consulted with the Company's nominated adviser, Cairn Financial Advisers LLP, consider the terms of the CLNs are fair and reasonable insofar as the Company's shareholders are concerned.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

[vlad the impaler] 28/4/2024 16:23

In fact, dig a bit - no exaggeration

[vlad the impaler] 28/4/2024 16:22

property developers - property buyers + markets

They would have to burn every financial district in the west and every knut that ever mentioned markets

[vlad the impaler] 28/4/2024 16:17

If you couldnt buy Nomads and makers etc in the UK, the likes of opti and sbtx would be 0.00001p

And if you did those podcasts in China or vietnam, re CEO's creating a narrative post real RNS's such as financials , get the death penalty haha

[vlad the impaler] 28/4/2024 16:09

SBTX has same style

They get sudden spikes from bad sentiment. it ensures gerbils are only buying rapid share price walk-ups and ramp blags at highs, for the sellers

[vlad the impaler] 28/4/2024 16:05

Jees july 2021 had a rise too. Brazen

More slow

lol

[vlad the impaler] 28/4/2024 16:04

Whats even more laughable is what the maker used to walk price up fast for high end distribution

[vlad the impaler] 28/4/2024 16:02

He may be hoping for the common July catch high spike before all the gerbils go on summer hols and cant be sold confetti for a few weeks re OPTI

If he is in for a trade, dangerous one this year. Rare to be so brazen as to go for 3 in a row.

[jonesy27] 28/4/2024 15:52

I read on LSE that swanny took part in the Opti placing. I’m hoping he doesn’t jump onboard any of my stocks

[vlad the impaler] 28/4/2024 15:51

By the end of month, CHLL will look like a hybrid pope and apple

[vlad the impaler] 28/4/2024 15:49

Bit bored talking about this one. We could discuss opti page by page, section by section, mostly because i am in knut mode

Im going to wholly ignore any comment about chll for a month, and go in drip drip mode on what i read

[vlad the impaler] 28/4/2024 13:17

And totally agree with II's view on quoted window re 2-1.8

Thats where the real truth shall be seen, off market so off SP, so to speak

[vlad the impaler] 28/4/2024 13:16

Ive seen that report. And the statistics dataflows changes compared to historic periods, is astounding

But that is only my read of it. Never one to tell others what to do